amikacin has been researched along with Myocardial Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, EH; Koch, WJ; Lau, WB; Li, R; Liang, B; Ma, XL; Wang, YJ; Yuan, YX; Zhang, Y; Zhao, J | 1 |
1 other study(ies) available for amikacin and Myocardial Ischemia
Article | Year |
---|---|
AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
Topics: Adiponectin; Administration, Oral; AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Heart Ventricles; Hypoglycemic Agents; Male; Mice, Knockout; Mice, Transgenic; Mutant Proteins; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxidative Stress; Piperidines; Random Allocation; Receptors, Adiponectin; Signal Transduction | 2015 |